INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
QM

Quigley Jill M.

DirectorCIK 0001799780

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score23
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
2
QM
Quigley Jill M.Director
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$227K
24.5K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Terns Pharmaceuticals, Inc.Director · Nov 5, 2025
23
QM
Quigley Jill M.Director
TERNTerns Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL
$441K
24.5K sh
Nov 4, 2025
Nov 5, 2025
traded Nov 4, 2025
+1d
SEC FORM 4

Evidence

0
QM
Quigley Jill M.Director
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
24.5K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC FORM 4

Evidence